| For: | Bhandari M, Pradhan A, Vishwakarma P, Singh A, Sethi R. Sodium glucose cotransporter 2 inhibitors in the management of heart failure: Veni, Vidi, and Vici. World J Cardiol 2024; 16(10): 550-563 [PMID: 39492976 DOI: 10.4330/wjc.v16.i10.550] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v16/i10/550.htm |
| Number | Citing Articles |
| 1 |
V.M. Zhdan, Ye.M. Kitura, M.Yu. Babanina, H.V. Volchenko, O.A. Kyrіan, M.V. Tkachenko, I.V. Ivanitsky, V.G. Lebid. Heart failure and metabolic syndrome: the role of sodium-glucose cotransporter-2 inhibitors in clinical practice. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2026; 22(5) doi: 10.22141/2224-0721.22.5.2026.1748
|
| 2 |
Shigenori Ito. Triumph or Just Victory? Current Status of Sodium-Glucose Cotransporter-2 Inhibitors across Heart Failure Spectrum. European Journal of Biomedical Research 2024; 3(5) doi: 10.24018/ejbiomed.2024.3.5.106
|